Gilead poach­es new phar­ma de­vel­op­ment and man­u­fac­tur­ing chief from cell ther­a­py 2.0 play­er

Gilead has raid­ed one of the up-and-com­ing cell ther­a­py 2.0 biotechs to find its new head of phar­ma de­vel­op­ment and man­u­fac­tur­ing.

Dan O’Day’s phar­ma play­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER